DarkPulse Inc. Announces Plan for an IPO of its Subsidiary, Optilan, on the New York Stock Exchange
We are delighted to announce our intention via @DarkPulseTech to take Optilan public in the United States mid-2022 via an Initial Public Offering (IPO), signaling a new phase in the company’s growth.
We are delighted to announce our intention via @DarkPulseTech to take Optilan public in the United States mid-2022 via an Initial Public Offering (IPO), signalling a new phase in the company’s growth.
On November 15, 2021, the Board of Directors of DarkPulse, Inc., a Delaware corporation (the “Company”), authorized and approved a share repurchase program for up to $15,000,000 of the currently outstanding shares of the Company’s common stock over a period of 12 months.
On November 17, 2021, the Company issued press release which announced the share repurchase program.